According to OncoCyte 's latest financial reports the company's current revenue (TTM) is -$2.37 M. In 2022 the company made a revenue of -$2.87 M a decrease over the years 2021 revenue that were of $7.72 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | -$2.37 M | -17.62% |
2022 | -$2.87 M | -137.09% |
2021 | $7.72 M | 534.92% |
2020 | $1.21 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |